Monday, June 25 • 1:30pm - 2:00pm
#130: PAREXEL International Innovation Theater: The Innovation Imperative: The Future of Drug Development

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session

The Economist Intelligence Unit will unveil its independent research findings titled, “The Innovation Imperative: The Future of Drug Development.” Commissioned by PAREXEL, the report shows how four key innovations consistently improve industry success metrics such as enrollment rates, regulatory approval, and payer adoption. However, despite their quantifiable positive impact, their adoption appears low. The reasons for this “adoption lag” and potential solutions will be discussed.


PAREXEL International

avatar for Alberto Grignolo

Alberto Grignolo

Corporate VP PAREXEL Consulting, PAREXEL
Alberto Grignolo has 36+ years of experience as a regulatory and drug development professional including consulting for pharmaceutical and biotechnology companies. He is a driver of a successful worldwide consulting business and established PAREXEL’s Japan Consulting Services. He... Read More →
avatar for David Humphreys

David Humphreys

Head of Health Policy, EIU Healthcare, The Economist Intelligence Unit
David Humphreys is the Head of the Health Policy Practice for The Economist Intelligence Unit (EIU) Healthcare consulting division. He supports clients across the healthcare ecosystem by conducting evidence based analysis and health policy impact through the EIU’s clinical, macro... Read More →

Monday June 25, 2018 1:30pm - 2:00pm
Theater 1 Exhibit Hall Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA